We are very pleased to announce the addition of three leading international advisors of our community to our Scientific Advisory Board: Dominique Charron MD, PhD, Malek Kamoun, MD, PhD and Matthew Anderson, MD, PhD. The Advisors, chaired by Prof. Dimitri Monos, PhD from the Children’s Hospital of Philadelphia have expertise in HLA Immunogenetics and Transplantation Biology, in Clinical Histocompatibility Testing and Biomarker Discovery as well as research interests outside those fields in molecular biology, sequencing and genomics. The primary function of the SAB is to provide independent advice on matters of science and technology relating to the Omixon’s mission as a world leader in molecular diagnostics.

For more info, visit our Board of Directors page.